(HealthNewsDigest.com) –– In patients with morbid obesity, losing 20 pounds before knee replacement surgery (arthroplasty) leads to fewer hospital days and other outcome improvements, reports a study in the August 21, 2019 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
For severely obese patients, “Losing at least 20 pounds was associated with lower absolute length of stay, lower odds of extended length of stay, and lower odds of being discharged to a facility,” according to the new research by David S. Jevsevar, MD, MBA, and colleagues of Dartmouth-Hitchcock Medical Center, Lebanon, N.H.
How Much Weight Loss Is Needed to Improve Outcomes in Morbidly Obese Patients?
The study was designed to assess the benefits of weight loss before total knee arthroplasty in patients with morbid obesity (body mass index 40 kg/m2 or higher). “Many surgeons require or request weight loss among morbidly obese patients before total knee arthroplasty,” the researchers write. That concern reflects consistent evidence showing increased rates of adverse outcomes in severely or morbidly obese patients.
Dr. Jevsevar and colleagues reviewed data on 203 morbidly obese patients who underwent total knee arthroplasty between 2011 and 2016 at one medical center. This group accounted for 13.5 percent of approximately 1,500 patients who underwent knee replacement during that time.
In the months before the procedure, 41 percent of patients lost at least five pounds, 29 percent lost at least 10 pounds, and 14 percent lost at least 20 pounds. The researchers compared the outcomes of each preoperative weight-loss group with those of patients who did not lose weight.
Several outcomes were improved in patients who lost 20 pounds or more, but not in those who lost five or 10 pounds. After adjusting for other factors, the researchers found that patients who lost at least 20 pounds spent about one fewer day in the hospital and were 76 percent less likely to have an extended hospital stay of four days or longer. Weight loss of at least 20 pounds was also associated with a 72 percent reduction in the odds of being discharged from the hospital to a facility.
Preoperative weight loss was not associated with change in operative time or with postoperative improvement in physical health and function. Length of hospital stay and operative time were significantly increased for patients who gained weight before surgery.
Most patients who lost 20 pounds or more remained in the morbidly obesity category, the researchers note, and patients displayed “general and expected” postoperative weight gain, with the mean weight almost returning to the preoperative baseline.
Although morbid obesity is associated with increased surgical risk, it remains unclear whether preoperative weight loss can improve outcomes following total knee arthroplasty. Dr. Jevsevar and coauthors note that larger, multicenter center studies are needed to confirm their findings.
Meanwhile, this study provides orthopaedic surgeons with new evidence that weight loss of 20 pounds or more – even if only temporary – can improve length-of-stay outcomes and reduce costs of total knee arthroplasty in morbidly obese patients. Dr. Jevsevar and colleagues conclude: “Providers may want to focus on larger, specific amounts of weight loss in morbidly obese patients preparing for total knee arthroplasty.”
Click here to read “Preoperative Weight Loss for Morbidly Obese Patients Undergoing Total Knee Arthroplasty”
About The Journal of Bone & Joint Surgery
The Journal of Bone & Joint Surgery (JBJS) has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field. A core journal and essential reading for general as well as specialist orthopaedic surgeons worldwide, The Journal publishes evidence-based research to enhance the quality of care for orthopaedic patients. Standards of excellence and high quality are maintained in everything we do, from the science of the content published to the customer service we provide. JBJS is an independent, non-profit journal.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2018 annual revenues of €4.3 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 18,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.